⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

AN2 Therapeutics, Inc. Common Stock

$4.18
-0.16 (-3.69%)

Volume:

49.063K ($205.08K)

Market Capitalization:

$157.74M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

AN2 Therapeutics Market Segments

Regular Trading Hours

-0.20(-4.57%)
Open$4.38
Close$4.18
Low$4.16
Low Change-0.22 (-5.02%)
High$4.55
High Change+0.17 (+3.88%)
Range$0.39
Volume49.063K
Dollar Volume$205.08K

Premarket

*No Trades in Segment

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$4.35
Close$4.35
Low$4.35
Low Change0.00 (0.00%)
High$4.35
High Change+0.00 (+0.00%)
Range$0.00
Volume12.112K
Dollar Volume$52.69K

Regular Trading Hours Yesterday

-0.20(-4.41%)
Open$4.54
Close$4.34
Low$4.24
Low Change-0.30 (-6.58%)
High$4.64
High Change+0.10 (+2.20%)
Range$0.40
Volume270.72K
Dollar Volume$1.17M

Premarket Yesterday

+0.00(+0.00%)
Open$4.54
Close$4.54
Low$4.54
Low Change0.00 (0.00%)
High$4.54
High Change+0.00 (+0.00%)
Range$0.00
Volume100
Dollar Volume$454.00

AN2 Therapeutics News

There is no current news for this stock at the moment.

AN2 Therapeutics Top Trades

AN2 Therapeutics's top trade so far today returned +3.88%, while the top short trade returned -8.13%.

AN2 Therapeutics Moving Averages

5 Day Moving Average (SMA5)$4.40
10 Day Moving Average (SMA10)$4.00
20 Day Moving Average (SMA20)$4.04
50 Day Moving Average (SMA50)$4.87
100 Day Moving Average (SMA100)$5.01
200 Day Moving Average (SMA200)$4.09

AN2 Therapeutics Statistics

Average Volume (30 Days)272.51K
P/E Ratio (Current)-4.58
EPS (Current)-$0.96
Dividend Yield0.00%
Free Cash Flow-$30.68M
Cash Ratio7.94
Current Ratio14.32
Quick Ratio14.32
Debt to Equity0.00
Enterprise Value$121.72M
EV to EBITDA-3.14
EV to Sales—
Price to Book2.19
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-0.44%
Return on Equity-0.48%

AN2 Therapeutics Stock Splits

There have been no stock splits for AN2 Therapeutics (ANTX).

AN2 Therapeutics Dividends

There have been no dividends for AN2 Therapeutics (ANTX).